Centroid bids for golf equipment maker TaylorMade Seoul-based private equity firm shortlisted for sale of U.S. golf company
이 기사는 2021년 04월 12일 08:17 더벨 유료페이지에 표출된 기사입니다.Centroid Investment Partners is vying for TaylorMade, one of the largest golf equipment makers in the world, the latest sign of the growing interest of private equity in the golf industry.
The Seoul-based firm has advanced alongside rival bidders from the U.S. and China to the final round of bidding for the U.S. golf company owned by KPS Capital Partners, according to industry sources.
The shortlisted bidders started due diligence. The U.S. investment firm hired Morgan Stanley earlier this year to run an auction for the company. It is expected to receive final offers and select a preferred buyer as early as at the end of this month.
Founded in 1979, TaylorMade is one of the leading golf equipment makers alongside Acushnet and Callaway Golf. Its revenue shrank from $1.7 billion in 2012 to $900 million in 2017. That year, KPS Capital Partners bought the brand from Adidas for $425 million.
The company has seen a rapid rebound in financial performance for the past years thanks to increased investments in marketing and new offerings. The brand has struck partnerships with star players such as Tiger Woods, Dustin Johnson and Rory McIlroy.
The golf industry benefited from coronavirus lockdowns, which helped boost the popularity of the sport globally. According to research firm Golf Datatech, golf equipment sales in the U.S. rose 10.1% year-on-year to $2.8 billion in 2020, the highest in 15 years. Rounds played were also up 13.9% in the same period, the largest increase since the firm started collecting data in 1998.
The deal, if signed, is expected to be worth 1.5 trillion won ($1.33 billion) to 2 trillion won, which would be the largest transaction in the sector, outsizing the $1.2 billion takeover of Acushnet by a consortium of Fila Korea and Mirae Asset Private Equity in 2011. (Reporting by Se-hun Jo)
최신뉴스 in 전체기사
- 인선이엔티, 실적 성장 이끈 '자동차 재활용'
- 휴머니젠, 코로나 치료제 FDA 긴급사용승인 신청 예정
- IPO관련 조직 확대가 '대세'? 실무진 인력난 심화
- 하이센스바이오, IPO 주관사 '한국투자증권' 낙점
- [발행사분석]현대비앤지스틸, 공모채 자신감…영업이익률 '껑충'
- [Market Watch]한국물 끝 없는 유동성 유입, 악재 뚫고 승승장구
- [Deal Story]제주맥주, 수요예측 '대박'…오버행 우려 지속 아쉬움
- 이지스자산운용, 업계 최초 ESG채권 찍는다…그린·소셜 형태
- NHN고도 IPO 대표 주관사에 대신증권 선정
- [Deal Story]JB우리캐피탈, SRI채권으로 그룹 ESG경영 힘싣는다
Translated by Ryu Ho-joung 의 다른 기사 보기
더벨 서비스 문의
02-724-4102유료 서비스 안내